Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Isoniazid；Rifapentine
Locations
1
China
Wenling No.1 People's Hospital, Zhejiang
Taizhou, Zhejiang, China
Start Date
December 1, 2018
Primary Completion Date
January 1, 2022
Completion Date
June 1, 2022
Last Updated
April 5, 2019
Lead Sponsor
Huashan Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions